Aileen David-Wang

875 citations
15 papers · 669 · 1 hit paper · h-index 7

Impact in

Papers in

    • Asthma and respiratory diseases 6
    • Clinical Laboratory Practices and Quality Control 1
    • COVID-19 Clinical Research Studies 3

Aileen David-Wang

13 papers receiving 648 citations

Aileen David-Wang's Hit Papers

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses 2022 · 290 citations
2900+1+2Years since publication50100150200250

Peers

Aileen David-Wang
Comparison fields: 5 of 59
  • Molecular Medicine 132
  • Infectious Diseases 231
  • Applied Microbiology and Biotechnology 17
  • Critical Care and Intensive Care Medicine 28
  • Physiology 147
Replace Salvatore Nappa with:
Salvatore Nappa Italy
Navaneeth Narayanan United States
Carmen Margarita Hernández‐Cardenas Mexico
Lorenzo Bertolino Italy
Marwa O. Elgendy Egypt
Elizabeth Leung Canada
Tina M. Khadem United States
Tim T Y Lau Canada
Angelina E Davis United States
Prayudi Santoso Indonesia
Aileen David-Wang relative to Salvatore Nappa Italy Salvatore Nappa's profile →
Citations per field
00.5×5×11.3×
Salvatore Nappa · 1×
Citations per year

Countries citing papers authored by Aileen David-Wang

Since Specialization
Citations

This map shows the geographic impact of Aileen David-Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aileen David-Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aileen David-Wang more than expected).

Fields of papers citing papers by Aileen David-Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aileen David-Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aileen David-Wang. The network helps show where Aileen David-Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Aileen David-Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aileen David-Wang Line = papers co-authored together Aileen David-Wang links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Hit paper breakdown →
2022290
2 2020173
3 201583
4 199769
5 201621
6 201610
7 20178
8 20185
9 20233
10 20142
11 20212
12 19941
13 20191
14 20231
15 20250

About Aileen David-Wang

Aileen David-Wang is a scholar working on Physiology, Infectious Diseases, Oncology, Critical Care and Intensive Care Medicine and Toxicology, having authored 15 papers that have together received 669 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (6 papers), COVID-19 Clinical Research Studies (3 papers), Nosocomial Infections in ICU (1 paper), Clinical Laboratory Practices and Quality Control (1 paper), COVID-19 and healthcare impacts (1 paper), Pneumonia and Respiratory Infections (1 paper), Biosimilars and Bioanalytical Methods (1 paper) and Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Molecular Medicine (132 citations), Infectious Diseases (231 citations), Applied Microbiology and Biotechnology (17 citations), Critical Care and Intensive Care Medicine (28 citations) and Physiology (147 citations). Aileen David-Wang has collaborated with scholars based in Philippines, South Korea and Hong Kong. Frequent co-authors include Kenneth R. Chapman, Steven Kesten, Nicola Alexander Hanania, Sang‐Heon Cho, David Price, Nicholas A. Kartsonis, Richard G. Wunderink, Helen W. Boucher, Antoine Roquilly and Ivan Titov. Their work appears in journals such as The Lancet, Clinical Infectious Diseases, Allergy Asthma and Immunology Research, Value in Health Regional Issues and Therapeutic Drug Monitoring.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact